Question to the Wales Office:
To ask the Secretary of State for Wales, with reference to his correspondence of 19 February 2021 to the chair of the Welsh Affairs Committee, what (a) discussions and (b) support his Department provided the pharmaceutical company in question; and when engagement with that company began.
Officials in my Office had several discussions with the company, including in regard to difficulties the company was experiencing in exporting medicines to the EU after the Transition Period ended. Officials from several government departments offered the company advice, guidance and expertise to help resolve these difficulties.
My officials first contacted the company directly on 12 January. Discussions had taken place earlier via business representative organisations.